INTRODUCTION {#S1}
============

Nonsense-mediated decay (NMD) is a ubiquitous pathway in eukaryotic cells that recognizes and degrades messenger RNAs (mRNAs) containing premature termination codons (PTCs) ([@R45]). Transcripts that harbor nonsense or frameshift mutations frequently undergo rapid degradation by NMD, limiting production of truncated proteins. As a result, the NMD pathway is a potent modifier of genetic disease phenotypes, protecting from deleterious activity of dominant-negative truncated proteins or exacerbating loss-of-function phenotypes by dampening production of truncated proteins with residual activity ([@R35]; [@R42]; [@R43]; [@R64]). Although first discovered because of this mRNA quality control function, it is now appreciated that a broad set of physiologic transcripts is targeted for accelerated decay by NMD, with approximately 10% of the mammalian transcriptome under control of this pathway ([@R13]; [@R62]; [@R88]). Accordingly, the NMD pathway is essential for embryogenesis in mammals, and its impairment is associated with neurodevelopmental disorders and cancer ([@R37]; [@R52]; [@R60]; [@R61]; [@R89]; [@R91]; [@R94]).

The events that occur when a ribosome reaches a termination codon dictate whether the NMD pathway will be engaged. For the vast majority of mammalian transcripts, the termination codon is located in the final exon or close to the final exon-exon junction. During splicing, the position of exon-exon junctions is stably marked by deposition of exon junction complexes (EJCs), which remain associated with the mRNA as it is exported to the cytoplasm ([@R48]). As a translating ribosome traverses the mRNA, it displaces EJCs, normally leading to their complete removal by the time it reaches the termination codon at the 3′ end of the open reading frame (ORF). The release factor eRF1 then enters the empty A site of the ribosome and, together with eRF3, promotes peptide release ([@R28]). Finally, ABCE1, an iron-sulfur (Fe-S) cluster-containing protein, is recruited to the terminating ribosome by eRF1 and facilitates splitting of the 40S and 60S subunits, a process known as ribosome recycling ([@R5]; [@R69]; [@R97]). In the absence of ABCE1 or its yeast homolog Rli1, unrecycled ribosomes move into the 3′ untranslated region (UTR), where they may aberrantly re-initiate translation ([@R65]; [@R87]; [@R97]).

When a stop codon is present at least 50 nucleotides (nt) upstream of the final exon-exon junction, translation termination occurs in the context of a downstream EJC remaining bound to the mRNA. This configuration represents the classic trigger for activation of NMD in mammalian cells ([@R7]; [@R27]; [@R45]). In this scenario, the core NMD factors UPF1 and SMG1 are recruited to the terminating ribosome by eRF1 and eRF3 and interact with UPF2 and UPF3B, which are anchored on the downstream EJC. The formation of this complex stimulates phosphorylation of UPF1 by SMG1, leading to recruitment of SMG5, SMG6, and SMG7. SMG6, an endonuclease, cleaves the mRNA, whereas SMG5 and SMG7 recruit the deadenylase and decapping machinery to promote degradation of the targeted nonsense transcript. NMD may also be triggered when a message has an unusually long 3′ UTR ([@R8]; [@R32]; [@R41]), a particularly important feature of the pathway in budding yeast, where most genes lack introns. The mechanisms that lead to recruitment of NMD factors and subsequent activation of the pathway in the absence of a downstream EJC, however, remain incompletely understood.

Evidence suggests that ribosome recycling occurs through distinct mechanisms at normal termination codons versus PTCs. Binding of UPF1 and SMG1 to eRF1/3 at PTCs likely precludes recruitment of ABCE1 ([@R9]). Moreover, it has been reported that the ATPase activity of yeast Upf1 is required for translation termination and ribosome recycling at PTCs ([@R82]), and human UPF3B has been shown to exhibit ribosome recycling activity in an *in vitro* translation assay ([@R68]). These data suggest that the UPF complex performs the ribosome recycling function at nonsense codons, although a role of ABCE1 in post-termination events at PTCs has not yet been directly examined.

Genetic screens have played a key role in elucidating the mechanism of NMD, with the UPF and SMG proteins having been identified through screens performed in yeast and nematodes, respectively ([@R30]; [@R50]). More recently, advances in CRISPR-Cas9 and RNA interference (RNAi) have enabled extension of this strategy to mammalian cells. [@R1] utilized a lentiviral CRISPR library coupled with fluorescence-activated cell sorting (FACS) of a reporter cell line to identify NMD regulators in HeLa cells. Although new potential NMD factors were identified in this study, the use of multiple rounds of sorting likely reduced the genome-wide coverage of this screen. A recent small interfering RNA (siRNA) screen that uncovered NMD factors in HEK293 cells likely avoided this caveat ([@R3]), but the short duration of siRNA-mediated knockdown may have precluded identification of long-lived NMD regulators or pathways that act upstream of core NMD factors. Thus, additional NMD factors may remain to be discovered in mammalian cells.

We recently developed a highly effective genome-wide CRISPR screening approach that utilizes fluorescent reporters coupled with a single round of high-stringency sorting that allows recovery of essential genes as hits ([@R25]; [@R56]). Here we describe application of this strategy to identify components of the NMD pathway in mammalian cells. Surprisingly, these experiments revealed that NMD requires activity of the vacuolar ATPase (V-ATPase), which is responsible for lysosomal acidification, as well as Fe-S cluster biogenesis and the Fe-S cluster-containing ribosome recycling factor ABCE1. We demonstrate that inhibition of lysosomal acidification compromises transferrin-mediated iron uptake, which, in turn, impairs Fe-S cluster biogenesis and abrogates ABCE1 activity. Loss of ABCE1 leads to accumulation of ribosomes in the 3′ UTRs of NMD targets, which displace downstream EJCs and reduce recruitment of UPF1 to nonsense transcripts. Remarkably, these effects are not limited to NMD targets, with ABCE1 deficiency leading to broad impairment of 3′ UTR-mediated post-transcriptional control, including mRNA turnover induced by microRNAs (miRNAs), AU-rich elements (AREs), N6-methyladenosine (m6A), and various RNA binding proteins (RBPs). Thus, ABCE1-mediated ribosome recycling is critical for preventing displacement of diverse 3′ UTR-bound messenger ribonucleoprotein (mRNP) complexes that confer post-transcriptional gene regulation. Importantly, the sensitivity of Fe-S clusters to intracellular iron levels and reactive oxygen species (ROS) results in vulnerability of 3′ UTR-directed regulation to lysosomal dysfunction, iron deficiency, and oxidative stress.

RESULTS {#S2}
=======

A Genome-wide CRISPR Screen in Human Cells Identifies Regulators of NMD {#S3}
-----------------------------------------------------------------------

To carry out a genome-scale CRISPR-Cas9 screen to identify new components or regulators of the NMD pathway in human cells, we expressed an enhanced green fluorescent protein (*EGFP*) reporter transcript that is efficiently targeted for degradation by NMD. Exons 2 and 3 as well as the intervening intron of the human β-globin (*HBB*) gene were cloned downstream of the *EGFP* ORF, positioning the exon-exon junction 231 nt downstream of the termination codon, creating an NMD substrate termed *EGFP*^PTC-231^ ([Figure 1A](#F1){ref-type="fig"}). A control transcript with the HBB intron placed 35 nt downstream of the *EGFP* stop codon, too close to trigger NMD ([@R11]; [@R10]), was also constructed (*EGFP*^PTC-35^; [Figure 1A](#F1){ref-type="fig"}). Half-life measurements of these transcripts expressed from a doxycycline-repressible promoter confirmed that *EGFP*^PTC-231^ is degraded much more rapidly than *EGFP*^PTC-35^ ([Figure 1B](#F1){ref-type="fig"}), consistent with elimination by the NMD pathway.

The *EGFP*^PTC-231^ and *EGFP*^PTC-35^ constructs were then placed under the control of a strong constitutive promoter and integrated into the *AAVS1* locus, a region of open chromatin that allows high-level transgene expression ([@R29]; [@R46]), in HCT116 cells, a stably diploid human cell line amenable to pooled CRISPR screening ([@R25]; [@R56]). As expected, *EGFP*^PTC-231^ cells exhibited approximately 10-fold lower GFP fluorescence compared with *EGFP*^PTC-35^ cells ([Figure 1C](#F1){ref-type="fig"}). To verify that decreased expression of *EGFP*^PTC-231^ was a consequence of downregulation by NMD, reporter cells were infected with lentiviruses expressing Cas9 and single guide RNAs (sgRNAs) targeting the established NMD factors SMG5 and SMG6 ([Figure 1D](#F1){ref-type="fig"}). Deficiency of either gene robustly increased EGFP expression in *EGFP*^PTC-231^ but not *EGFP*^PTC-35^ cells, demonstrating that expression of the *EGFP*^PTC-231^ reporter provided a reliable readout of NMD activity.

*EGFP*^PTC-231^ and *EGFP*^PTC-35^ cells were then infected with a genome-wide lentiviral CRISPR library targeting approximately 19,000 human genes ([@R18]; [Figure 1E](#F1){ref-type="fig"}). Ten days after transduction, the brightest 0.5% of cells, representing those with impaired repression of the *EGFP* reporter, were collected by FACS. sgRNA representation in sorted and unsorted cells was determined by high-throughput sequencing, and model-based analysis of genome-wide CRISPR-Cas9 knockout (MAGeCK) ([@R51]) was used to identify genes targeted by sgRNAs that were enriched in sorted populations ([Table S1](#SD2){ref-type="supplementary-material"}). Genes that scored as significant hits in *EGFP*^PTC-231^ cells (p \< 0.001), but not in *EGFP*^PTC-35^ cells, represented potential NMD factors and were selected for further analysis ([Figure 1F](#F1){ref-type="fig"}). Based on this cutoff, the majority of established NMD factors were recovered as significant hits ([Figures 1G](#F1){ref-type="fig"} and [S1A](#SD1){ref-type="supplementary-material"}), confirming the ability of this screening approach to identify components and regulators of the NMD pathway.

The screen identified numerous potential NMD regulators that have not been associated previously with the pathway ([Table S1](#SD2){ref-type="supplementary-material"}). Gene Ontology (GO) analysis revealed that, in addition to factors linked to mRNA processing, transport, and metabolism, genes associated with lysosomal acidification and Fe-S cluster assembly were unexpectedly enriched among the hits ([Figure S1B](#SD1){ref-type="supplementary-material"}; [Table S2](#SD3){ref-type="supplementary-material"}). Further examination of these classes of genes uncovered several components of the V-ATPase, which is responsible for acidification of the endosome/lysosome ([@R66]; [Figure 1H](#F1){ref-type="fig"}), and several factors necessary for Fe-S cluster biogenesis as well as the Fe-S cluster-containing protein ABCE1 ([Figure 1I](#F1){ref-type="fig"}) as significant hits. Because of the unknown mechanisms through which these factors influence NMD, we elected to further study their role in the pathway.

V-ATPase Activity Is Required for NMD {#S4}
-------------------------------------

To validate the requirement for V-ATPase function in NMD, *EGFP*^PTC-231^ and *EGFP*^PTC-35^ cells were infected with lentiviral vectors encoding Cas9 and sgRNAs targeting 4 subunits of the complex (*ATP6V0C*, *ATP6V0B*, *ATP6AP1*, or *ATP6V1B2*) ([Figures 2A](#F2){ref-type="fig"}, [S2A](#SD1){ref-type="supplementary-material"}, and [S2B](#SD1){ref-type="supplementary-material"}). Knockout of each of these genes robustly increased the GFP signal in *EGFP*^PTC-231^ cells while only minimally affecting expression of the *EGFP*^PTC-35^ reporter. Western blotting confirmed a strong increase in EGFP protein levels in *ATP6V0C* knockout *EGFP*^PTC-231^ cells ([Figure S2C](#SD1){ref-type="supplementary-material"}). In agreement with these results, treatment with bafilomycin, a V-ATPase inhibitor, significantly increased GFP fluorescence in *EGFP*^PTC-231^ cells, with minor effects on expression of *EGFP*^PTC-35^ ([Figure S2D](#SD1){ref-type="supplementary-material"}).

Because V-ATPase-mediated lysosomal acidification is essential for protein hydrolysis within the lysosome, we initially postulated that the protein encoded by the *EGFP*^PTC-231^ mRNA might be targeted for lysosome-mediated degradation by the NMD machinery. Nevertheless, surprisingly, we observed that the increase in EGFP expression in *ATP6V0C* knockout *EGFP*^PTC-231^ cells was due to an increase in reporter mRNA expression ([Figure 2B](#F2){ref-type="fig"}). Conversely, no increase in *EGFP*^PTC-35^ mRNA abundance was detected upon knockout of *ATP6V0C* ([Figure 2C](#F2){ref-type="fig"}). Similar results were observed in bafilomycin-treated cells ([Figures S2E](#SD1){ref-type="supplementary-material"} and [S2F](#SD1){ref-type="supplementary-material"}). These results suggested an unexpected role of V-ATPase in decay of NMD target transcripts. Further corroborating this conclusion, half-life measurements documented that *EGFP*^PTC-231^ mRNA was stabilized by *ATP6V0C* knockout or bafilomycin treatment ([Figures 2D](#F2){ref-type="fig"} and [S2G](#SD1){ref-type="supplementary-material"}).

To verify that these effects were not limited to the *EGFP*^PTC-231^ reporter, we assessed the expression of several established endogenous NMD targets, including *ATF3*, *GADD45A*, *GADD45B*, *DNAJB2*, and an alternatively spliced isoform of SRSF2 with multiple introns in its 3′ UTR ([@R26]; [@R62]; [@R88]). All tested NMD targets were significantly upregulated in *ATP6V0C* knockout and bafilomycin-treated cells ([Figures 2E](#F2){ref-type="fig"}, [2F](#F2){ref-type="fig"}, and [S2H](#SD1){ref-type="supplementary-material"}). Last, we demonstrated that the requirement for V-ATPase activity in NMD was not limited to HCT116 cells because treatment of Huh7, HeLa, and HEK293T cells with bafilomycin similarly increased expression of endogenous NMD target genes ([Figure S2I](#SD1){ref-type="supplementary-material"}). Taken together, these data document that accelerated transcript degradation through the NMD pathway requires activity of the V-ATPase complex.

Iron Depletion in V-ATPase-Deficient Cells Inhibits NMD {#S5}
-------------------------------------------------------

Transferrin-mediated iron uptake, the major mechanism of iron absorption in mammalian cells, requires V-ATPase activity. Extracellular iron in complex with transferrin is bound by the transferrin receptor (TFRC) and taken up by receptor-mediated endocytosis ([@R14]; [Figure 3A](#F3){ref-type="fig"}). V-ATPase-mediated acidification of the endosomal/lysosomal compartment triggers release of iron, which is transported to the cytoplasm for use in cellular metabolism, including incorporation into Fe-S clusters. Given the preponderance of genes required for Fe-S cluster biogenesis among the top hits in the screen ([Figure 1I](#F1){ref-type="fig"}), we hypothesized that the requirement for V-ATPase activity in NMD may be due to its role in iron absorption.

Although *TFRC* did not initially score among the top hits, the gene was highly ranked in the *EGFP*^PTC-231^ screen (rank 283, top 1.5%; [Table S1](#SD2){ref-type="supplementary-material"}), and transferrin transport was highlighted as a significantly enriched GO term among the hits ([Figure S1B](#SD1){ref-type="supplementary-material"}). Accordingly, *TFRC* knockout increased reporter fluorescence and mRNA abundance in *EGFP*^PTC-231^ but not *EGFP*^PTC-35^ cells ([Figures 3B](#F3){ref-type="fig"}-[3E](#F3){ref-type="fig"}, [S3A](#SD1){ref-type="supplementary-material"}, and [S3B](#SD1){ref-type="supplementary-material"}). Moreover, treatment with the iron chelator desferrioxamine (DFO) resulted in similar effects on reporter expression ([Figures S3C](#SD1){ref-type="supplementary-material"} and [S3D](#SD1){ref-type="supplementary-material"}) and stabilized the *EGFP*^PTC-231^ transcript ([Figure S3E](#SD1){ref-type="supplementary-material"}). These results indicated that TFRC-mediated iron uptake is required for NMD.

confirmed that inhibition of lysosomal acidification with bafilomycin reduced intracellular iron levels, as measured by an established flow cytometry assay based on iron-mediated quenching of calcein-AM (CA-AM) fluorescence ([@R71]; [Figure 3F](#F3){ref-type="fig"}). Treatment with iron citrate, which is taken up through an endocytosis-independent mechanism ([@R86]), replenished intracellular iron. Furthermore, iron citrate supplementation fully reversed the increase in reporter fluorescence in *ATP6V0C* knockout and bafilomycin-treated *EGFP*^PTC-231^ cells ([Figures 3G](#F3){ref-type="fig"} and [S3F](#SD1){ref-type="supplementary-material"}). Additionally, *EGFP*^PTC-231^ mRNA and endogenous NMD target abundance were restored to control levels under these conditions ([Figures 3H](#F3){ref-type="fig"} and [S3G](#SD1){ref-type="supplementary-material"}). Thus, impairment of NMD in V-ATPase-deficient cells is attributable to intracellular iron deficiency.

Deficiency of Fe-S Cluster Biogenesis or the Fe-S Cluster-Containing Protein ABCE1 Impairs NMD {#S6}
----------------------------------------------------------------------------------------------

Sufficient intracellular iron is necessary for biogenesis of Fe-S clusters, which are assembled in mitochondria and then exported to the cytoplasm for incorporation into target proteins ([@R75]; [Figure 1I](#F1){ref-type="fig"}). Several proteins in this pathway were recovered as significant hits in the screen, including the mitochondrial assembly factors NFS1 and HSCB, the ABCB7 transporter, and the cytosolic Fe-S chaperones NUBP1, NARFL, CIAO1, YAE1D1, and ORAOV1. Interestingly, the only Fe-S cluster recipient protein among the top hits was the ribosome recycling factor ABCE1, strongly implicating an essential role of ABCE1 and its associated Fe-S cluster in the NMD pathway. Notably, we observed that *ATP6V0C* knockout or bafilomycin treatment potently reduced ABCE1 protein abundance ([Figure 4A](#F4){ref-type="fig"}). This finding is consistent with the requirement for adequate intracellular iron for Fe-S cluster biogenesis, which, in turn, is necessary for ABCE1 protein stability ([@R87]).

In keeping with the screening results, targeting of *HSCB*, *NARFL*, *YAE1D1*, and *ORAOV1* with lentivirally delivered CRISPR components increased GFP fluorescence in *EGFP*^PTC-231^ but not *EGFP*^PTC-35^ cells ([Figure S4A](#SD1){ref-type="supplementary-material"}). Similarly, ABCE1 knockout strongly increased the fluorescence and mRNA abundance of the *EGFP*^PTC-231^ but not the *EGFP*^PTC-35^ reporter ([Figures 4B](#F4){ref-type="fig"}-[4D](#F4){ref-type="fig"}, [S4B](#SD1){ref-type="supplementary-material"}, and [S4C](#SD1){ref-type="supplementary-material"}) and stabilized the *EGFP*^PTC-231^ transcript ([Figure 4E](#F4){ref-type="fig"}). Endogenous NMD target transcripts were similarly increased in multiple cell lines after *ABCE1* depletion ([Figures 4F](#F4){ref-type="fig"}, [4G](#F4){ref-type="fig"}, [S4D](#SD1){ref-type="supplementary-material"}, and [S4E](#SD1){ref-type="supplementary-material"}). These data support a requirement for Fe-S cluster biogenesis and ABCE1 in NMD.

It has been reported that depletion of ABCE1 globally reduces translation ([@R90]). Because of the dependency of NMD on active translation, this could potentially account for impaired decay of nonsense transcripts in ABCE1-deficient cells. Nevertheless, under the conditions utilized in these experiments, we observed only a minor reduction in overall translation upon ABCE1 loss of function, as assessed by incorporation of fluorescent O-propargyl-puromycin (OPP) into newly translated proteins ([Figure S4F](#SD1){ref-type="supplementary-material"}). Further arguing against an indirect effect on general translation as the cause of NMD inhibition, we observed that knockout of the Fe-S cluster biogenesis factor *ORAOV1* or *ABCE1* resulted in a robust increase in EGFP protein in *EGFP*^PTC-231^ cells ([Figure S4G](#SD1){ref-type="supplementary-material"}). Thus, NMD targets were still actively translated under these conditions. Additionally, the lack of translation factors among the significant hits in the CRISPR screen suggested that globally reduced translation does not result in an increase in *EGFP*^PTC-231^ reporter fluorescence.

To investigate the broader effects of ABCE1 deficiency on NMD-regulated transcripts, RNA sequencing (RNA-seq) was performed on ABCE1-depleted HCT116 cells. Examination of a high-stringency set of NMD target genes, representing the overlap of two previous gene expression studies of cells with UPF1, SMG6, and/or SMG7 deficiency ([@R13]; [@R20]), documented that NMD targets were globally upregulated in ABCE1 knockout cells ([Figure 4H](#F4){ref-type="fig"}). Transcripts that are targeted for cleavage by SMG6 ([@R81]) were also upregulated ([Figure 4I](#F4){ref-type="fig"}). NMD of the *EGFP*^PTC-231^ reporter is initiated by an EJC downstream of the termination codon. Upstream ORFs (uORFs) and long 3′ UTRs have also been shown to induce NMD, albeit with lower potency ([@R45]). Expression of transcripts harboring these features was also globally increased upon ABCE1 depletion ([Figures S4H](#SD1){ref-type="supplementary-material"} and [S4I](#SD1){ref-type="supplementary-material"}). Taken together, these data establish that NMD induced by a variety of triggers requires the activity of ABCE1.

Unrecycled Ribosomes Downstream of Termination Codons Displace EJCs on NMD Targets in ABCE1-Deficient Cells {#S7}
-----------------------------------------------------------------------------------------------------------

Although it has been suggested that the UPF complex carries out the ribosome recycling function at PTCs ([@R9]; [@R68]; [@R82]), our data demonstrating a requirement for ABCE1 in NMD suggested an essential role of canonical ribosome recycling in decay of nonsense transcripts. To examine this directly, we performed ribosome profiling in ABCEI-deficient cells, which allowed determination of the positions of ribosomes on transcripts undergoing NMD. As expected, ribosome-protected fragments exhibited 3-nt periodicity within ORFs, consistent with the stepwise translation of each codon ([Figure S5A](#SD1){ref-type="supplementary-material"}). In accordance with data reported previously ([@R65]; [@R87]; [@R97]), loss of ABCE1 resulted in queuing of ribosomes at termination codons and an increase in ribosomes within 3′ UTRs ([Figures 5A](#F5){ref-type="fig"}, [S5A](#SD1){ref-type="supplementary-material"}, and [S5B](#SD1){ref-type="supplementary-material"}).

To determine whether ABCE1 is required for ribosome recycling on an NMD substrate transcript, we examined ribosome occupancy on the *EGFP*^PTC-231^ mRNA. Indeed, a large increase in ribosomes within the *EGFP*^PTC-231^ 3′ UTR was observed in ABCE1-depleted cells ([Figure 5B](#F5){ref-type="fig"}). Moreover, increased ribosome occupancy was clearly detectable downstream of the exon-exon junction ([Figures 5B](#F5){ref-type="fig"} and [5C](#F5){ref-type="fig"}), strongly suggesting that unrecycled ribosomes are able to displace EJCs as they move through the 3′ UTR.

We next used RNA immunoprecipitation (RIP) to directly assess EJC occupancy downstream of termination codons on NMD sub-strates. The *EGFP*^PTC-231^ transcript has only a single exon-exon junction, located within the 3′ UTR ([Figure 5B](#F5){ref-type="fig"}). The alternatively spliced variant of *SRSF2* that is an NMD substrate has multiple exon-exon junctions in its 3′ UTR ([Figure 2F](#F2){ref-type="fig"}), and the single EJC in the *SRSF2* coding region will be efficiently removed during translation. Thus, steady-state EJC association with these transcripts largely or entirely represents binding of this complex downstream of the termination codon. *CASC3* binding sites are highly specific markers of the location of EJCs ([@R26]), and CASC3 knockout results in a global increase in NMD targets ([@R24]). Indeed, CASC3 was the most highly ranked hit in our screen ([Table S1](#SD2){ref-type="supplementary-material"}) and was also identified in other published NMD screens ([@R1]; [@R3]). Pull-down of CASC3 revealed a significant decrease in EJC occupancy within the 3′ UTRs of *EGFP*^PTC-231^ and NMD-sensitive *SRSF2* transcripts in ABCE1-deficient cells ([Figures 5D](#F5){ref-type="fig"}, [S5C](#SD1){ref-type="supplementary-material"}, and [S5D](#SD1){ref-type="supplementary-material"}). Finally, in keeping with the presence of unrecycled ribosomes in 3′ UTRs and displacement of EJCs, the association of UPF1 with *EGFP*^PTC-231^ and the NMD-sensitive isoform of *SRSF2* was significantly decreased upon loss of ABCE1 ([Figures S5E](#SD1){ref-type="supplementary-material"}-[S5G](#SD1){ref-type="supplementary-material"}). Collectively, these ribosome profiling and RIP results demonstrate that deficiency of ABCE1 leads to accumulation of ribosomes distal to the termination codon on NMD target transcripts, resulting in dissociation of downstream EJCs and impaired recruitment of the NMD machinery.

Oxidative Stress or Lysosomal Dysfunction Impairs Ribosome Recycling and NMD {#S8}
----------------------------------------------------------------------------

It has been reported that ROS damage Fe-S clusters, reducing ABCE1 protein stability and leading to defective ribosome recycling ([@R2]; [@R23]; [@R87]). The effect of ROS on ABCE1 protein abundance was recapitulated in HCT116 cells by exposure to paraquat, a potent ROS-inducing compound ([Figure 6A](#F6){ref-type="fig"}). As shown above, impaired lysosomal acidification has a similar effect on ABCE1 levels ([Figure 4A](#F4){ref-type="fig"}). To confirm that these forms of cellular stress manifest in a ribosome recycling defect, we employed a dual-luciferase reporter system in which a *Renilla* luciferase ORF is followed by a firefly luciferase ORF, the latter of which will be translated when the intervening stop codon is bypassed by unrecycled ribosomes ([Figure 6B](#F6){ref-type="fig"}). Indeed, we observed that loss of ABCE1, impairment of lysosomal acidification, or generation of ROS strongly induced translation of the downstream ORF. Moreover, paraquat treatment potently inhibited NMD, as evidenced by a robust increase in fluorescence, EGFP mRNA, and EGFP protein in *EGFP*^PTC-231^ reporter cells ([Figures 6A](#F6){ref-type="fig"}, [6C](#F6){ref-type="fig"}, and [6D](#F6){ref-type="fig"}). Endogenous NMD target genes were markedly upregulated as well. Supporting the model that impaired ABCE1-mediated ribosome recycling causes displacement of EJCs downstream of termination codons under these conditions, CASC3 RIP demonstrated that paraquat or bafilomycin treatment reduced EJC occupancy in the 3′ UTRs of *EGFP*^PTC-231^ and NMD-sensitive SRSF2 transcripts ([Figures 6E](#F6){ref-type="fig"}, [6F](#F6){ref-type="fig"}, and [S6](#SD1){ref-type="supplementary-material"}). These data demonstrate that the Fe-S cluster of ABCE1 links oxidative stress and lysosomal dysfunction to the NMD pathway.

Loss of ABCE1-Mediated Ribosome Recycling Broadly Impairs 3′ UTR-Directed Post-transcriptional Regulation {#S9}
---------------------------------------------------------------------------------------------------------

The binding of diverse RNP complexes to mRNA 3′ UTRs results in a broad array of post-transcriptional regulatory outcomes, including altered mRNA stability, translation, or localization ([@R58]). Given our finding that loss of ABCE1-mediated ribosome recycling results in displacement of EJCs as ribosomes move beyond the termination codon on NMD substrates, we hypothesized that unrecycled ribosomes might similarly displace other regulatory factors that are encountered as 3′ UTRs are traversed. miRNAs represent a highly studied class of post-transcriptional repressors that recruit Argonaute (AGO) proteins to target sites predominantly within 3′ UTRs ([@R22]). Remarkably, we observed global upregulation of mRNAs that are regulated by AGO2 ([@R25]) in ABCE1-deficient HCT116 cells ([Figure 7A](#F7){ref-type="fig"}). AREs represent another class of 3′ UTR *cis* elements that recruit proteins such as KHSPR, TIA1/TIAL1, AUF1, and TTP to accelerate mRNA decay ([@R84]). As observed for miRNA targets, ARE-containing transcripts ([@R4]) were broadly upregulated upon depletion of ABCE1 ([Figure S7A](#SD1){ref-type="supplementary-material"}). Similar effects were observed for transcripts modified by m6A ([@R92]), which recruits YTHDF2 to accelerate mRNA turnover ([@R85]; [@R92]; [Figure 7B](#F7){ref-type="fig"}) as well as for transcripts bound by TIA1 or RC3H1 ([@R63]; [@R67]; [Figures S7B](#SD1){ref-type="supplementary-material"} and [S7C](#SD1){ref-type="supplementary-material"}), RBPs that promote decay of their targets ([@R67]; [@R95]). To confirm that upregulation of these classes of transcripts was not due to general impairment of mRNA turnover, we examined targets of the RBP HuR, which can stabilize mRNAs to which it binds. Indeed, downregulation of HuR targets ([@R49]) was observed in ABCE1-deficient cells ([Figure 7C](#F7){ref-type="fig"}).

We further assessed whether impaired lysosomal acidification or oxidative stress, which compromise ABCE1 function, similarly inhibit 3′ UTR-directed post-transcriptional regulation. The expression of transcripts that are regulated by ABCE1 and are targets of various post-transcriptional regulatory pathways were examined by RNA-seq after bafilomycin or paraquat treatment. Similar to the effects of ABCE1 depletion, bafilomycin ([Figures 7D](#F7){ref-type="fig"}, [7E](#F7){ref-type="fig"}, and [S7D](#SD1){ref-type="supplementary-material"}-[S7F](#SD1){ref-type="supplementary-material"}) or paraquat ([Figures 7G](#F7){ref-type="fig"}, [7H](#F7){ref-type="fig"}, and [S7G](#SD1){ref-type="supplementary-material"}-[S7I](#SD1){ref-type="supplementary-material"}) upregulated targets of AGO2, YTHDF2, TIA1, and RC3H1 as well as ARE-containing mRNAs, whereas HuR targets were downregulated under these conditions ([Figures 7F](#F7){ref-type="fig"} and [7I](#F7){ref-type="fig"}). In addition, we documented that miRNA targets, m6A-modified mRNAs, and TIA1-bound transcripts that were highly upregulated in ABCE1 knockout cells were similarly upregulated upon iron chelation ([Figure S7J](#SD1){ref-type="supplementary-material"}). Altogether, these data demonstrate that efficient ABCE1-mediated ribosome recycling, which is impaired by lysosomal dysfunction, disruption of iron homeostasis, or oxidative stress, is essential for maintaining the activity of a broad set of post-transcriptional regulatory pathways.

DISCUSSION {#S10}
==========

The 3′ UTR is a privileged region of an mRNA that is critical for appropriate post-transcriptional regulation. Although the 5′ UTR and ORF must be traversed by ribosomal subunits or translating ribosomes, 3′ UTRs are free of this constraint and are instead bound by diverse mRNP complexes that confer a variety of regulatory outcomes on the transcript, including altered mRNA localization, stability, and translation ([@R58]). NMD can be thought of as a specialized form of 3′ UTR-directed regulation where the presence of an EJC downstream of the termination codon or other features indicative of an atypical 3‱ UTR, such as excessive length, trigger accelerated mRNA decay ([@R9]). Here we describe a previously unrecognized mechanism that governs 3′ UTR-directed regulation. Specifically, we demonstrated that efficient removal of ribosomal subunits at termination codons by the ribosome recycling factor ABCE1 is essential to maintain the accessibility of 3′ UTRs to a broad array of regulatory assemblies, including EJCs, miRNA-AGO complexes, and RBPs. Furthermore, the Fe-S cluster that serves as a crucial co-factor for ABCE1 is a key vulnerability that connects lysosomal function, iron metabolism, and oxidative stress to 3′ UTR-mediated post-transcriptional control.

A Genetic Screen Reveals a V-ATPase/Fe-S Cluster/ABCE1 Pathway that Is Essential for NMD {#S11}
----------------------------------------------------------------------------------------

This study reports the results of a comprehensive genome-wide CRISPR-Cas9 screen to identify components and regulators of the human NMD pathway. Because of the ability of our screening methodology to achieve prolonged gene knockout while retaining the sensitivity to recover essential genes as hits, these experiments uncovered many putative NMD factors that have not been associated previously with the pathway. We anticipate that this dataset will be a valuable resource for the field, complementing previous genetic screens performed in model organisms ([@R30]; [@R50]) and other human cell lines ([@R1]; [@R3]).

We were particularly intrigued by two classes of genes that uniquely emerged from our screen: components of the V-ATPase and proteins required for Fe-S cluster biogenesis. Functional dissection of these pathways revealed that NMD requires lysosomal acidification to maintain transferrin-mediated iron uptake, which, in turn, is necessary for biogenesis of the Fe-S cluster that serves as an essential co-factor for ABCE1. ABCE1 promotes efficient dissociation of ribosomal subunits at termination codons, and its loss results in movement of ribosomes into 3′ UTRs. On NMD substrates, unrecycled 3′ UTR ribosomes displace EJCs, preventing recruitment of the NMD machinery and subsequent accelerated decay of the transcript ([Figure 7J](#F7){ref-type="fig"}).

Ribosome Recycling, NMD, and 3′ UTR-Directed Regulation {#S12}
-------------------------------------------------------

ABCE1-mediated ribosome recycling is initiated when the eRF1-eRF3 complex completes the process of peptide release at a terminating ribosome. At this stage, eRF3 dissociates, enabling ABCE1 to bind to the site it previously occupied on eRF1 ([@R6]; [@R70]). However, at NMD-inducing termination codons, UPF1 and SMG1 are recruited to terminating ribosomes that are thought to be still occupied by eRF1 and eRF3 ([@R40]). In this scenario, ABCE1 would be physically constrained from joining the termination complex. Furthermore, ATP hydrolysis by Upf1 is required to dissociate ribosomes at PTCs in yeast ([@R82]), whereas human UPF3B can promote ribosome recycling *in vitro* ([@R68]). These findings support the existence of distinct ribosome recycling mechanisms at NMD- and non-NMD-inducing termination codons ([@R9]).

How can a requirement for ABCE1 in efficient decay of NMD substrates be reconciled with the evidence suggesting an alternative mechanism of ribosome recycling at stop codons that initiate NMD? Recent results from single-molecule studies of the kinetics of NMD in living cells provide key insights into this question ([@R31]). It has been proposed that NMD exclusively occurs during a pioneer round of translation ([@R36]; [@R57]; [@R80]), although evidence supporting activation of NMD during later rounds of translation has also been reported ([@R19]; [@R76]). The evidence provided by [@R31] indicates that each translating ribosome has an equal probability of inducing NMD, with approximately eight rounds of translation occurring before accelerated decay of a nonsense transcript occurs. This scenario provides an opportunity for ABCE1-dependent and ABCE1-independent ribosome recycling to operate on the same transcript. Because the probability of NMD activation by the first ribosome is relatively low, ABCE1 activity is necessary to prevent ribosome leakage into the 3′ UTR, which would displace EJCs and impair recruitment of the NMD machinery during later rounds of translation. It is worth noting that movement of only a single ribosome through the 3′ UTR is likely sufficient to clear bound EJCs, rendering a transcript resistant to NMD, which likely explains the potent inhibitory effect of ABCE1 deficiency on NMD despite the relatively low steady-state 3′ UTR ribosome occupancy observed under this condition ([Figure 5A](#F5){ref-type="fig"}).

The removal of 3′ UTR-bound regulatory factors by unrecycled ribosomes is not limited to NMD-inducing complexes such as EJCs. In principle, any *trans*-effector bound to the 3′ UTR may be displaced as ribosomes aberrantly move downstream of the termination codon. Indeed, by examining the targets of diverse post-transcriptional regulators, we found evidence of widespread impairment of 3′ UTR-directed mRNA control in ABCE1-deficient cells. Observed defects included impaired miRNA-, ARE-, and m6A-mediated transcript decay as well as reduced regulation by diverse RBPs. Thus, efficient ribosome recycling by ABCE1 is needed to maintain the appropriate mRNP configuration downstream of the stop codon to enable activity of a broad set of post-transcriptional regulatory pathways ([Figure 7J](#F7){ref-type="fig"}).

The Fe-S Cluster of ABCE1 Links Lysosomal Function, Iron Availability, and Oxidative Stress to 3′ UTR-Directed Regulation {#S13}
-------------------------------------------------------------------------------------------------------------------------

Impaired lysosomal acidification is strongly associated with many diseases, particularly multiple forms of congenital or acquired neurodegeneration ([@R12]). In addition to disease-associated mutations in genes encoding V-ATPase subunits that directly disable lysosomal acidification, defects in enzymes that cause lysosomal storage diseases also impair acidification of this organelle ([@R21]; [@R38]; [@R72]; [@R96]; [@R98]). Because an acidic pH is essential for hydrolysis of proteins and other cellular constituents within the lysosome, pathogenesis of diseases in this context has traditionally been ascribed to toxic accumulation of lysosomal material. It is now understood, however, that lysosomal dysfunction results in much broader effects on cellular signaling and metabolism ([@R54]). For example, because of the dependence of transferrin-mediated iron uptake upon an acidic lysosomal pH, lysosomal defects cause a deficiency of intracellular iron. Iron depletion is a major toxic consequence of lysosomal dysfunction in yeast and mammalian cells ([@R33]; [@R93]). Previous work largely attributed the deleterious effects of iron deficiency to mitochondrial dysfunction. The results presented here add an additional dimension to our understanding of the consequences of lysosomal dysfunction and iron deficiency on cellular physiology. The impairment of Fe-S cluster biogenesis that occurs under these conditions ultimately inactivates ABCE1, leading to widespread loss of 3′ UTR-mediated regulation and inactivation of the NMD pathway. Thus, the Fe-S cluster of ABCE1 broadly links lysosomal function and iron availability to post-transcriptional control. These effects represent an important additional mechanism that likely contributes to the deleterious phenotypic consequences resulting from lysosomal abnormalities.

The presence of oxidative stress is another condition that leads to inhibition of NMD. Previously, this effect was attributed to the ability of ROS to activate the integrated stress response ([@R39]; [@R55]), in which phosphorylation of eIF2a globally reduces bulk translation while selectively increasing translation of factors that facilitate stress adaptation. Because of the dependency of NMD on ongoing translation, this scenario would be expected to lead to global stabilization of nonsense transcripts. Importantly, the Fe-S cluster of ABCE1 is also known to be highly susceptible to damage by ROS ([@R2]). Accordingly, ROS-inducing agents abrogate ABCE1-mediated ribosome recycling and cause ribosomal accumulation within 3′ UTRs ([@R87]). Our studies confirmed that ROS generation potently inhibits NMD and is associated with removal of EJCs downstream of termination codons. Thus, loss of ribosome recycling contributes to impairment of NMD in the presence of oxidative stress. Importantly, the widespread requirement for efficient ribosome recycling in 3′ UTR-directed regulation provides a mechanism through which oxidative stress may affect gene expression much more broadly. Given the prevalence of elevated ROS in many pathologic conditions, including mitochondrial dysfunction, aging, and cancer ([@R15]; [@R77]), the Fe-S cluster of ABCE1 is a key vulnerability that may connect diverse disease conditions to defective post-transcriptional control ([Figure 7J](#F7){ref-type="fig"}).

STAR★METHODS {#S14}
============

RESOURCE AVAILABILITY {#S15}
---------------------

### Lead Contact {#S16}

Requests for further information or reagents should be directed to the lead contact, Joshua T. Mendell (<Joshua.Mendell@UTSouthwestern.edu>).

### Materials Availability {#S17}

All reagents generated in this study are available upon request from the Lead Contact with a completed Materials Transfer Agreement.

### Data and Code Availability {#S18}

All high-throughput sequencing data generated in this study (CRISPR screening, RNA-seq, and ribosome profiling) have been deposited in GEO (Accession number GEO: GSE144165). No custom code was generated in this study.

EXPERIMENTAL MODEL AND SUBJECT DETAILS {#S19}
--------------------------------------

Human cell lines were obtained from ATCC. HCT116 cells (male) were cultured in McCoy′s 5A media (Invitrogen) supplemented with 10% (v/v) fetal bovine serum (Sigma) and 1X Antibiotic-Antimycotic (Invitrogen). HEK293T (most likely female due to the presence of multiple X chromosomes and no detectable Y chromosome), Huh7 (male), and HeLa (female) were cultured in Dulbecco′s Modified Eagle′s Medium (DMEM) (Invitrogen) supplemented with 10% (v/v) fetal bovine serum (Sigma) and 1X Antibiotic-Antimycotic (Invitrogen). Cell lines were confirmed to be free of mycoplasma contamination.

METHOD DETAILS {#S20}
--------------

### Construction of NMD reporter plasmids {#S21}

A DNA fragment containing *HBB* exon 2 (231bp), intron 2, and exon 3 was amplified from human genomic DNA by PCR with Phusion High-Fidelity DNA Polymerase (New England Biolabs) and cloned into pAAVS-*EGFP*-DONOR ([@R56]) XbaI and MfeI sites using NEBuilder HiFi DNA Assembly Master Mix (New England Biolabs) to generate pAAVS-*EGFP*^PTC-231^. A sub-fragment of *HBB*, beginning 35 bp upstream of the of the 3′ end of exon 2, was amplified from pAAVS-*EGFP*^PTC-231^ and cloned into pAAVS-*EGFP*-DONOR XbaI and MfeI sites to generate pAAVS-*EGFP*^PTC-35^. Primer sequences are provided in [Table S3](#SD4){ref-type="supplementary-material"}.

### Generation of NMD reporter cell lines {#S22}

Plasmids expressing TALEN pairs targeting the human *AAVS1/PPP1R12C* locus (Addgene \#35431 and \# 35432) ([@R78]) and pAAVS-*EGFP*^PTC-231^ or pAAVS-*EGFP*^PTC-35^ were co-transfected into HCT116 cells using FuGENE HD transfection reagent (Promega) at a ratio of Left TALEN:Right TALEN:*EGFP*^PTC-231^ or pAAVS-*EGFP*^PTC-35^ = 1:1:5. Two days after transfection, selection with 200 μg/ml hygromycin (ThermoFisher Scientific) was initiated and maintained for ten days. Single cell clones were then derived and screened for reporter fluorescence.

### Genome-wide CRISPR-Cas9 screening {#S23}

#### Virus preparation {#S24}

The Brunello library (Addgene \#73179) ([@R18]) was amplified in Endura Electrocompetent cells (Lucigen) and sequenced to confirm maintenance of sgRNA representation. Virus was generated by transfecting HEK293T cells growing in 10 cm dishes with 5 μg Brunello library plasmid, 3 μg psPAX2 (Addgene \#12260), and 2 μg pMD2.G (Addgene \#12259) using 30 μL FuGENE HD transfection reagent. Supernatant was collected at 48 hours and 72 hours post-transfection and stored at −80°C.

#### Cell transduction and sorting {#S25}

Screening was performed in two independent *EGFP*^PTC-231^ clones and two independent *EGFP*^PTC-35^ clones. For each clone, 1.35 × 10^8^ cells were seeded into nine 15 cm dishes (1.5 × 10^7^ cells/dish), followed immediately by addition of 8 μg/ml of polybrene (Millipore) and lentiviral library at a multiplicity of infection of \~0.3 in order to achieve \~500X coverage of the library. Two days post-transduction, cells were re-seeded into media containing 1 μg/ml puromycin (ThermoFisher Scientific) and selected for eight days, during which time cells were passaged every 2 or 3 days as needed. After selection, 6 × 10^7^ cells were sorted per clone using a Mo-Flo cell sorter (Beckman Coulter), collecting the brightest 0.5% of cells. At least 2 × 10^5^ sorted cells and 4 × 10^7^ unsorted cells for each clone were used for genomic DNA isolation.

#### Genomic DNA isolation, sgRNA amplification, sequencing, and data analysis {#S26}

Genomic DNA (gDNA) was isolated from sorted cells by phenol--chloroform extraction as described ([@R25]). gDNA was isolated from unsorted cells using the MasterPureTM Complete DNA Purification Kit (Lucigen). sgRNAs were amplified from gDNA using Herculase II Fusion DNA Polymerase (Agilent) using two sequential rounds of PCR. For unsorted cells, 6.6 μg of gDNA (repre-senting approximately 1 × 10^6^ cells) were used in each 100 μL reaction for PCR 1, with 40 reactions used in total for each sample. For sorted cells, all recovered gDNA was split into two 100 μL reactions. After 18 cycles of amplification for PCR 1, reactions were pooled and 5 μL were used for a second round of PCR, consisting of 8-12 cycles, to append barcodes and adapters for Illumina sequencing. Primer sequences are provided in [Table S3](#SD4){ref-type="supplementary-material"}. Amplicons were purified using Agencourt AMPure XP beads (Beckman Coulter Life Sciences) and sequenced on an Illumina NextSeq500 with 75 bp single-end reads. Bowtie 2 ([@R47]) was used to map reads obtained from the demultiplexed FASTQ files to the reference library, allowing no mismatches, and normalized read counts were calculated as described ([@R83]). Approximately 2 × 107 reads were obtained for each sample. MAGeCK ([@R51]) was used to identify genes targeted by sgRNAs that were enriched in sorted cells versus unsorted cells. DAVID 6.8 was used for GO analysis of *EGFP*^PTC-231^-specific hits (<https://david.ncifcrf.gov/home.jsp>) ([@R16]).

### CRISPR-Cas9 mediated gene knockout {#S27}

sgRNAs targeting genes of interest, as well as non-target (NT) sgRNAs (sequences provided in [Table S3](#SD4){ref-type="supplementary-material"}), were cloned into the lenti-CRISPR v2 vector (Addgene \#52961) as previously described ([@R79]). Knockout pools were generated as described previously ([@R56]) with minor modifications. To generate *ABCE1*-knockout pools, transduced cells were selected with 1 μg/ml puromycin for 4 days (HCT116, Huh7, and HeLa) or 5 days (HEK293T) before analysis. To produce knockout pools for all other genes, transduced cells were selected with 1 μg/ml puromycin for 6 days before harvesting.

### Ribosome profiling {#S28}

Ribosome profiling was performed as described previously ([@R59]) with the following modifications:

1.  Ribosome footprints were size selected by gel electrophoresis as described previously ([@R34]), and fragments between 26-34nt were excised for library preparation.

2.  Samples were not pooled after linker ligation, and the subsequent steps were performed individually for each sample.

3.  3′ linker-ligated RNA fragments were purified using gel extraction as previously described ([@R34]).

4.  Ribosomal RNA was depleted as described previously ([@R34]).

### RNA-seq {#S29}

RNA was isolated using the RNeasy Mini kit (QIAGEN) and gDNA contamination was removed using the TURBO DNA-Free kit (ThermoFisher Scientific). Sequencing libraries were generated with the TruSeq Stranded mRNA Library Prep Kit (Illumina) and sequenced on a NextSeq 500 (Illumina) with 75-bp single-end reads.

### Measurement of EGFP reporter mRNA stability {#S30}

The *piggyBac* donor plasmid XLone-GFP (Addgene \#96930) ([@R73]) was modified by replacing the GFP (between KpnI and SpeI sites) with a DNA fragment containing NheI, BmtI, NotI, PstI, BglII, and PmeI sites to generate XLone-MCS. The rtTA sequence was then replaced with tTA, producing XLone-tTA-MCS. The *EGFP*^PTC-231^ or *EGFP*^PTC-35^ sequences were excised from pAAVS-*EGFP*^PTC-231^ or pAAVS-*EGFP*^PTC-35^, respectively, using KpnI and HpaI and cloned into the KpnI and PmeI sites of XLone-tTA-MCS. The resulting tetOFF-*EGFP*^PTC-231^ or tetOFF-*EGFP*^PTC-35^ plasmids, together with pCMV-hyPBase plasmid ([@R99]) which encodes the *piggyBac* transposase, were co-transfected into HCT116 cells and cells were selected with 5 μg/ml blasticidin (ThermoFisher Scientific) for 14 days to generate stable cell lines. For mRNA stability measurements, cells were treated with 1 μg/ml doxycycline (Sigma) for 0, 40, 80, or 120 minutes. qRT-PCR was used to assess reporter mRNA abundance relative to *GAPDH* mRNA at each time point.

### Western blotting {#S31}

Cells were lysed in RIPA buffer (Sigma). Proteins were separated by SDS-PAGE electrophoresis, transferred to nitrocellulose membranes, and detected using an infrared fluorescent antibody detection system (LI-COR). Antibodies are provided in the [Key Resources Table](#T1){ref-type="table"}.

### qRT-PCR {#S32}

RNA was isolated using the RNeasy Mini kit (QIAGEN) using on-column DNase digestion. PrimeScript RT Master Mix (Clontech) was used to synthesize cDNA from 1 μg total RNA and qRT-PCR was performed with the SYBR Green Master Mix (ThermoFisher Scientific). mRNA expression was normalized to *GAPDH* expression in all experiments. Primer sequences are provided in [Table S3](#SD4){ref-type="supplementary-material"}.

### Measurement of intracellular iron {#S33}

Calcein acetoxymethyl ester (CA-AM) (Abcam) was used to measure the intracellular labile iron pool in HCT116 cells as previously described ([@R71]) with the following modifications. Cells were trypsinized and washed twice with Hank's Balanced Salt Solution (HBSS, ThermoFisher Scientific) followed by incubation with 0.05 mM CA-AM in HBSS for 15 minutes with gentle shaking. After staining, cells were washed twice with HBSS and analyzed by flow cytometry.

### Bafilomycin, DFO, and paraquat treatment {#S34}

Bafilomycin (Fisher Scientific) was dissolved in DMSO, while desferrioxamine (DFO) (Sigma) and paraquat (Sigma) were dissolved in distilled water. An equal volume of vehicle was used as a control for all experiments. 6 × 10^4^ cells were seeded into each well of 12-well plate and drug treatments were initiated 24 hours later. For bafilomycin and DFO treatment, cells were treated with 5-10 nM bafilomycin or 8 mM DFO for 48 hours. For paraquat treatment, cells were treated with 200 μg/mL paraquat for a total of 96 hours. Media was changed 24 hours after the beginning of the paraquat treatment and cells were split 1:2 into a new 12-well plate 48 hours after drug addition.

### Iron (III) citrate treatment {#S35}

Iron (III) citrate (Sigma) was dissolved in distilled water. 24 hours after lentiviral delivery of Cas9 and non-target (NT) or *ATP6V0C*-targeting sgRNAs, 0.5 mM Iron (III) citrate was added to the medium. 48 hours after lentiviral transduction, fresh medium with 1 μg/ml puromycin and 0.5 mM Iron (III) citrate was added and cells were grown for an additional 6 days before harvesting. For bafilomycin/Iron (III) citrate co-treatment, 6 × 10^4^ cells were seeded into each well of 12-well plate with 0.5 mM Iron (III) citrate. 24 hours later, 5 nM bafilomycin was added to culture medium and cells were incubated for an additional 48 hours.

### Analysis of total protein synthesis with OPP {#S36}

Protein synthesis was assessed using the Protein Synthesis Assay Kit (Cayman Chemical) as described by the manufacturer. Briefly, cells were incubated with OPP Working Solution at 37°C for 30 minutes. Cells were then washed, fixed, and incubated in 5FAM-Azide staining solution in the dark at room temperature for 30 minutes followed by analysis by flow cytometry.

### RNA immunoprecipitation (RIP) {#S37}

RIP was performed as previously described ([@R44]). Briefly, 2 × 10^7^ cells grown in a 15 cm dish were harvested by scraping in 1 mL cold PBS. Cells were then washed twice with cold PBS and lysed in 1 mL hypotonic lysis buffer \[10 mM Tris--HCl (pH 7.4), 10 mM NaCl, 10 mM EDTA, 0.5% Triton X-100, 1x EDTA-free Protease inhibitor (Millipore), 1x PhosSTOP Phosphatase inhibitor (Sigma), 1x RNase inhibitor (New England Biolabs)\]. Following centrifugation at 15,000 g for 10 min at 4°C, the supernatant was pre-cleared using 50 μL Dynabeads Protein G (Invitrogen). Precleared lysate was added to 50 μL Dynabeads Protein G coupled with 3 μg antibody (anti-CASC3, Bethyl, A302-471A; anti-UPF1, Bethyl, A300-038A) and incubated at 4°C for 2 hours with end-over-end rotation. Beads were washed 2 times each in ice-cold NET-2 buffer-1 \[50 mM Tris--HCl (pH 7.4), 150 mM NaCl, 0.1% NP-40\], ice-cold NET-2 buffer-2 \[50 mM Tris--HCl (pH 7.4), 150 mM NaCl, 0.5% NP-40\], and high salt wash buffer \[20 mM Tris--HCl (pH 7.4), 325 mM NaCl, 2 mM EDTA, 1% Triton X-100, 0.1% SDS\]. Washed beads were resuspended in 120 μL lysis buffer. 20 μL was added to Laemmli buffer (Fisher Scientific) and used for western blot analysis (anti-CASC3, Bethyl, 302-472A; anti-UPF1, Santa Cruz, sc-393594), while the remaining 100 μL was added to 900 μL Trizol (Invitrogen) and used for RNA isolation and qRT-PCR analysis.

### Dual luciferase assay {#S38}

A *Renilla* luciferase ORF with or without a TAA termination codon was inserted upstream of firefly luciferase in pGL3-Control (Promega) to generate pGL3-Renilla-Ter-firefly and pGL3-Renilla-noTer-firefly plasmids, respectively. 3 × 10^4^ HCT116 cells were seeded into each well of a 12-well plate. 24 hours later, cells were transfected with 0.3 μg pGL3-Renilla-Ter-firefly or pGL3-Renilla-noTer-firefly plasmids using FuGENE HD transfection reagent (Promega). Beginning 12 hours post-transfection, cells were treated with 5 nM bafilomycin for 48 hours or 200 μg/mL paraquat for 72 hours. For analysis of *ABCE1* knockout, cells were transduced with lentiCRISPR vectors and then, 72 hours later, transfected with luciferase reporter plasmids. Beginning 24 hours after transfection, cells were selected in puromycin for 48 hours prior to luciferase assays. Luciferase activity was determined using the Dual-Luciferase Reporter Assay System (Promega Corporation). firefly/*Renilla* activity in pGL3-Renilla-Ter-firefly transfected cells was normalized to firefly/*Renilla* activity in pGL3-Renilla-noTer-firefly plasmid cells.

QUANTIFICATION AND STATISTICAL ANALYSIS {#S39}
---------------------------------------

### Analysis of RNA-seq and ribosome profiling data {#S40}

For RNA-seq, reads were mapped to hg19 using STAR ([@R17]), read counts were generated using featureCounts ([@R53]), and edgeR ([@R74]) was used to analyze differential gene expression. Only transcripts with CPM \> 0.5 were used for CDF analyses. Ribosome profiling data were analyzed as previously described ([@R56]).

### Statistical analysis {#S41}

All experiments were repeated with a minimum of three biological replicates. The Student′s t test and Kolmogorov-Smirnov test were used to determine statistical significance. All values are reported as mean ± SD in each figure.
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![A Genome-wide CRISPR-Cas9 Screen Identifies NMD Regulators\
(A) Schematic of *EGFP*^PTC-231^ and *EGFP*^PTC-35^ reporter constructs. Ter, termination codon.\
(B) Analysis of *EGFP*^PTC-231^ mRNA and *EGFP*^PTC-35^ mRNA stability in respective doxycycline-repressible (tetOFF)-*EGFP* cell lines. Cells were treated with 1 μg/mL doxycycline, and the *EGFP* mRNA level relative to *GAPDH* abundance at the indicated time points was determined by qRT-PCR.\
(C) Flow cytometry analysis of EGFP fluorescence in the indicated cell lines.\
(D) Flow cytometry analysis of *EGFP*^PTC-231^ cells and *EGFP*^PTC-35^ cells after lentiviral delivery of Cas9 and non-target (NT) or *SMG5*- or *SMG6*-targeting sgRNAs.\
(E) Schematic of the CRISPR-Cas9 screening strategy.\
(F) MAGeCK analysis of screening data. Hits within the dashed box represent those that met the significance threshold of p \< 0.001 in *EGFP*^PTC-231^ cells and p \> 0.001 in *EGFP*^PTC-35^ cells. Blue dots, known NMD factors; red dots, V-ATPase components; green dots, Fe-S biogenesis factors.\
(G--I) Known NMD factors (G), V-ATPase subunits (H), and genes required for Fe-S cluster biogenesis (I) that were recovered as significant hits in the screen. Data are represented as mean ± SD (n = 3 biological replicates for all qRT-PCR experiments). \*p \< 0.05, \*\*p \< 0.01; calculated by Student's t test. See also [Figure S1](#SD1){ref-type="supplementary-material"} and [Table S1](#SD2){ref-type="supplementary-material"}.](nihms-1612489-f0002){#F1}

![The V-ATPase Is Required for NMD\
(A) Flow cytometry analysis of *EGFP*^PTC-231^ cells after lentiviral delivery of Cas9 and NT or *ATP6V0C*-targeting sgRNAs.\
(B and C) qRT-PCR analysis of *EGFP*^PTC-231^ (B) or *EGFP*^PTC-35^ mRNA (C) in reporter cell lines after lentiviral delivery of Cas9 and the indicated sgRNAs. All mRNA expression levels shown in this figure were first normalized to *GAPDH* expression and then normalized to expression level in sgNT1-infected cells.\
(D) Analysis of *EGFP*^PTC-231^ mRNA stability in tet-OFF-*EGFP*^PTC-231^ cells after lentiviral delivery of Cas9 and the indicated sgRNAs. Cells were treated with 1 μg/mL doxycycline, and the *EGFP* mRNA level relative to *GAPDH* abundance at the indicated time points was determined by qRT-PCR.\
(E and F) qRT-PCR analysis of endogenous NMD targets (E) or PTC^+^ and PTC^−^ isoforms of *SRSF2* (F) in HCT116 cells after lentiviral delivery of Cas9 and the indicated sgRNAs.\
Data are represented as mean ± SD (n = 3 biological replicates for all qRT-PCR experiments). \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001; calculated by Student's t test. See also [Figure S2](#SD1){ref-type="supplementary-material"}.](nihms-1612489-f0003){#F2}

![Iron Deficiency Compromises NMD in V-ATPase-Deficient cells\
(A) Schematic representation of transferrin (TF)-mediated iron uptake. After receptor-mediated endocytosis via the TF receptor (TFRC), acidification of the endosome/lysosome by V-ATPase promotes iron release and transport to the cytoplasm.\
(B) Western blot analysis of the TFRC in *EGFP*^PTC-231^ cells after lentiviral delivery of Cas9 and NT or *TFPC*-targeting sgRNAs. α-Tubulin served as a loading control.\
(C) Flow Cytometry analysis of *EGFP*^PTC-231^ cells after lentiviral delivery of Cas9 and the indicated sgRNAs.\
(D and E) qRT-PCR analysis of *EGFP*^PTC-231^ (D) or *EGFP*^PTC-35^ mRNA(E) in reporter cell lines after lentiviral delivery of Cas9 and the indicated sgRNAs. All mRNA expression levels shown in this figure were first normalized to *GAPDH* expression and then normalized to expression level in sgNT1-infected cells.\
(F) Flow cytometry assay for intracellular iron content, based on calcein-AM (CA-AM) fluorescence, in control (DMSO)- or bafilomycin (5 nM)-treated HCT116 cells with or without 0.5 mM iron citrate supplementation.\
(G) Flow cytometry analysis of *EGFP*^PTC-231^ cells after lentiviral delivery of Cas9 and the indicated sgRNAs with or without 0.5 mM iron citrate supplementation.\
(H) qRT-PCR analysis of NMD targets in *EGFP*^PTC-231^ cells after lentiviral delivery of Cas9 and the indicated sgRNAs with or without 0.5 mM iron citrate supplementation.\
Data are represented as mean ± SD (n = 3 biological replicates for all qRT-PCR experiments). \*p \< 0.05, \*\*\*p \< 0.001; calculated by Student's t test. See also [Figure S3](#SD1){ref-type="supplementary-material"}.](nihms-1612489-f0004){#F3}

![ABCE1 Is Required for NMD\
(A) Western blot analysis of ABCE1 in *EGFP*^PTC-231^ cells after lentiviral delivery of Cas9 and NT or *ATP6V0C*-targeting sgRNAs (top) or treatment with bafilomycin (5 nM) or a control (DMSO) (bottom). α-Tubulin served as a loading control.\
(B) Western blot analysis of ABCE1 in *EGFP*^PTC-231^ cells after lentiviral delivery of Cas9 and NT or ABCE1-targeting sgRNAs.\
(C) Flow cytometry analysis of *EGFP*^PTC-231^ cells after lentiviral delivery of Cas9 and the indicated sgRNAs.\
(D) qRT-PCR analysis of *EGFP*^PTC-231^ or *EGFP*^PTC-35^ mRNA in reporter cell lines after lentiviral delivery of Cas9 and the indicated sgRNAs. All mRNA expression levels shown in this figure were first normalized to *GAPDH* expression and then normalized to expression level in sgNT1-infected cells.\
(E) Analysis of *EGFP*^PTC-231^ mRNA stability in tetOFF-*EGFP*^PTC-231^ cells after lentiviral delivery of Cas9 and the indicated sgRNAs. Cells were treated with 1 μg/mL doxycycline, and the *EGFP* mRNA level relative to *GAPDH* abundance at the indicated time points was determined by qRT-PCR.\
(F and G) qRT-PCR analysis of endogenous NMD targets (F) or PTC^+^ and PTC^−^ isoforms of *SRSF2* (G) in HCT116 cells after lentiviral delivery of Cas9 and the indicated sgRNAs.\
(H and I) Cumulative distribution function (CDF) plot demonstrating the effect of ABCE1 deficiency on expression of NMD target genes ([@R13]; [@R20]; H) or SMG6 substrates ([@R81]; I). FC, fold change.\
Data are represented as mean ± SD (n = 3 biological replicates for all qRT-PCR experiments). \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001; calculated by Student's t test; p values for CDF plots were calculated by one-sided Kolmogorov-Smirnov test. See also [Figure S4](#SD1){ref-type="supplementary-material"}.](nihms-1612489-f0005){#F4}

![Unrecycled Ribosomes Downstream of Ters in ABCE1-Depleted Cells Displace EJCs\
(A) Metagene analysis demonstrating ribosome occupancy in 3′ UTRs. A window spanning 100 nt upstream of termination codon (position 0) to 200 nt downstream of termination codon is shown. RPM, ribosome-protected fragments per million mapped reads.\
(B) Ribosome occupancy on the *EGFP*^PTC-231^ transcript after lentiviral delivery of Cas9 and the indicated sgRNAs. The position of the exon-exon junction in the in 3′ UTR of the reporter transcript is indicated. Ribosome occupancy is represented as the RPM value at a given position, normalized to the total RPM value in the *EGFP* ORF.\
(C) Total ribosome occupancy downstream of the exon-exon junction in the 3′ UTR of the *EGFP*^PTC-231^ transcript after lentiviral delivery of Cas9 and the indicated sgRNAs. For each condition, the total RPM downstream of the exon-exon junction was normalized to the total RPM value in the *EGFP* ORF.\
(D) qRT-PCR analysis of NMD targets (*EGFP*^PTC-231^ and *SRSF2*^PTC+^) andcontrol transcripts (*GAPDH* and *SMN*) in CASC3 RIP samples from cells expressing Cas9 and the indicated sgRNAs. For each transcript, enrichment was first normalized to input and then normalized to a paired control sample.\
Data are represented as mean ± SD (n = 3 biological replicates for all qRT-PCR experiments). \*p \< 0.05, \*\*\*p \< 0.001; calculated by Student's t test. See also [Figure S5](#SD1){ref-type="supplementary-material"}.](nihms-1612489-f0006){#F5}

![Oxidative Stress Inhibits ABCE1 and NMD\
(A) Western blot analysis of ABCE1 and EGFP protein in paraquat-treated (200 μg/mL) *EGFP*^PTC-231^ cells.\
(B) Activity of dual-luciferase reporters in HCT116 cells after lentiviral delivery of control or *ABCE1*-targeting sgRNAs, bafilomycin treatment (5 nM), or paraquat treatment (200 μg/mL). Firefly/Renilla activity in reporter-transfected cells was normalized to firefly/*Renilla* activity in noTer control-transfected cells.\
(C) Flow cytometry analysis of paraquat-treated *EGFP*^PTC-231^ cells.\
(D) qRT-PCR analysis of NMD targets or PTC^+^ and PTC^−^ isoforms of SRSF2 in paraquat- or control-treated *EGFP*^PTC-231^ cells. mRNA expression was first normalized to *GAPDH* expression and then normalized to expression level in control-treated cells.\
(E and F) qRT-PCR analysis of NMD targets (*EGFP*^PTC-231^ and *SRSF2*^PTC+^) and control transcripts (*GAPDH* and *SMN*) in CASC3 RIP samples from bafilomycin-treated (5 nM, E) or paraquat-treated (200 μg/mL, F) cells. For each transcript, enrichment was first normalized to input and then normalized to a paired control sample.\
Data are represented as mean ± SD (n = 3 biological replicates for all qRT-PCR and luciferase experiments). \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001; calculated by Student's t test. See also [Figure S6](#SD1){ref-type="supplementary-material"}.](nihms-1612489-f0007){#F6}

![Depletion of ABCE1 Broadly Impairs 3′ UTR-Directed Regulation\
(A--C) CDF plots showing the effects of ABCE1 deficiency on the expression of miRNA targets, defined as mRNAs with FC \> 1.5 in *AGO2*^−/−^ HCT116 cells compared with wild-type cells ([@R25]) (A), mRNAs with m6A modification that were bound by YTHDF2 ([@R92]) (B), or HuR targets defined as the 150 most downregulated HuR-bound mRNAs in HuR-deficient cells ([@R49]) (143 were expressed in HCT116 cells; C).\
(D--I) CDF plots showing the effect of bafilomycin treatment (5 nM, D--F) or paraquat treatment (200 μg/mL, G--I) on the targets of post-transcriptional regulators shown in (A--C). Targets in each plot were restricted to those that were increased (*AGO2* and YTHDF2 targets) or decreased (HuR targets) in *ABCE1* knockout cells to specifically examine transcripts whose levels are regulated by ribosome recycling.\
(J) ABCE1-mediated ribosome recycling links lysosomal dysfunction, iron-deficiency, and oxidative stress to 3′ UTR-directed post-transcriptional regulation and NMD. Lysosomal acidification is necessary for TF-mediated iron uptake, which is required for biogenesis of the Fe-S cluster that serves as a critical co-factor for ABCE1. Impaired ABCE1 function, occurring in the setting of reduced iron availability or elevated ROS, leads to movement of unrecycled ribosomes into 3′ UTRs, where they displace EJCs and other regulatory RNPs, disabling NMD and other forms of post-transcriptional regulation.\
The p values for CDF plots were calculated by one-sides Kolmogorov-Smirnov test. See also [Figure S7](#SD1){ref-type="supplementary-material"}.](nihms-1612489-f0008){#F7}

###### 

KEY RESOURCES TABLE

  REAGENT or RESOURCE                                                                                                SOURCE                              IDENTIFIER
  ------------------------------------------------------------------------------------------------------------------ ----------------------------------- ------------------------------------
  Antibodies                                                                                                                                             
  ABCE1 antibody                                                                                                     Novus Biologicals                   Cat\# NB400-116; RRID:AB_10002055
  CASC3 Antibody                                                                                                     Bethyl                              Cat\# A302-472A; RRID:AB_1944210
  CASC3 Antibody                                                                                                     Bethyl                              Cat\# A302-471A; RRID:AB_1944212
  UPF1 antibody                                                                                                      Bethyl                              Cat\# A300-038A; RRID:AB_2288326
  UPF1 antibody                                                                                                      Santa Cruz                          Cat\# sc-393594
  TFRC antibody                                                                                                      Bethyl                              Cat\# A304-381A-T; RRID:AB_2781867
  α-tubulin antibody                                                                                                 Sigma                               Cat\# T6199; RRID:AB_477583
  GFP antibody                                                                                                       Cell Signaling Technology           Cat\# 2956S; RRID:AB_1196615
  Bacterial and Virus Strains                                                                                                                            
  Endura Electrocompetent cells                                                                                      Lucigen                             Cat\# 60242-2
  Chemicals, Peptides, and Recombinant Proteins                                                                                                          
  FuGENE HD Transfection Reagent                                                                                     Promega Corporation                 Cat\# E2311
  Hygromycin B                                                                                                       ThermoFisher Scientific             Cat\# 10687010
  Puromycin (Puromycin Dihydrochloride)                                                                              ThermoFisher Scientific             Cat\# A11138-03
  Polybrene                                                                                                          Millipore                           Cat\# TR-1003-G
  Blasticidin                                                                                                        ThermoFisher Scientific             Cat\# A1113903
  Bafilomycin A1                                                                                                     Fisher Scientific                   Cat\# AAJ61835MCR
  Deferoxamine mesylate (DFO)                                                                                        Sigma                               Cat\# D9533
  Iron(III) citrate                                                                                                  Sigma                               Cat\# F6129
  Paraquat dichloride hydrate                                                                                        Sigma                               Cat\# 36541
  Protease Inhibitor Cocktail Set III, EDTA-Free                                                                     Millipore                           Cat\# 539134
  Doxycycline monohydrate                                                                                            Sigma                               Cat\# D1822
  Dulbecco′s Modified Eagle′s Medium (DMEM)                                                                          Invitrogen                          Cat\# 11995-073
  McCoy's 5A medium                                                                                                  Invitrogen                          Cat\# 12330031
  Fetal Bovine Serum (FBS)                                                                                           Sigma                               Cat\# F2442
  Antibiotic-antimycotic                                                                                             Invitrogen                          Cat\# 15240-112
  PhosSTOP Phosphatase inhibitor                                                                                     Sigma                               Cat\# 4906837001
  RNase Inhibitor                                                                                                    New England Biolabs                 Cat\# M0314L
  Laemmli buffer                                                                                                     Fisher Scientific                   Cat\# NC9165175
  TRIzol                                                                                                             Invitrogen                          Cat\# 15596026
  HBSS buffer                                                                                                        ThermoFisher Scientific             Cat\# 14025092
  RIPA Buffer                                                                                                        Sigma                               Cat\# R0278
  Calcein acetoxymethyl ester (CA-AM)                                                                                Abcam                               Cat\# ab141420
  Critical Commercial Assays                                                                                                                             
  Agencourt AMPure XP beads                                                                                          Beckman Coulter Life Sciences       Cat\# A63882
  Qubit dsDNA HS Assay Kit                                                                                           ThermoFisher Scientific             Cat\# Q32851
  Direct-zol RNA Miniprep Kit                                                                                        Zymo Research                       Cat\# R2051
  SYBR Green PCR Master Mix                                                                                          ThermoFisher Scientific             Cat\# 4309155
  Phusion High-Fidelity DNA Polymerase                                                                               New England Biolabs                 Cat\# M0530S
  NEBuilder HiFi DNA Assembly Master Mix                                                                             New England Biolabs                 Cat\# E2621S
  TURBO DNA-free kit                                                                                                 ThermoFisher Scientific             Cat\# AM1907
  PrimeScript RT Master Mix (Perfect Real Time)                                                                      Clontech                            Cat\# RR036A
  RNeasy Mini Kit                                                                                                    QIAGEN                              Cat\# 74106
  Herculase II Fusion DNA Polymerase                                                                                 Agilent                             Cat\# 600679
  Protein Synthesis Assay Kit                                                                                        Cayman Chemical                     Cat\# 601100
  TruSeq Stranded mRNA Library Prep Kit                                                                              Illumina                            Cat\# RS-122-2101
  Dynabeads Protein G                                                                                                Invitrogen                          Cat\# 10004D
  Dynabeads® MyOne Streptavidin T1                                                                                   Invitrogen                          Cat\# 65601
  Dual-Luciferase® Reporter Assay System                                                                             Promega Corporation                 Cat\# E1980
  MasterPureTM Complete DNA Purification Kit                                                                         Lucigen                             Cat\# MC85200
  Deposited Data                                                                                                                                         
  CRISPR screening data                                                                                              This paper                          GEO: GSE144165
  Ribosome profiling data from ABCE1-knockout cells                                                                  This paper                          GEO: GSE144165
  RNA-seq data from ABCE1-knockout cells                                                                             This paper                          GEO: GSE144165
  RNA-seq data from Bafilomycin-treated cells                                                                        This paper                          GEO: GSE144165
  RNA-seq data from Paraquat-treated cells                                                                           This paper                          GEO: GSE144165
  Experimental Models: Cell Lines                                                                                                                        
  pAAVS-*EGFP*^PTC-231^ cells                                                                                        This paper                          N/A
  pAAVS-*EGFP*^PTC-35^ cells                                                                                         This paper                          N/A
  tetOFF-*EGFP*^PTC-231^ cells                                                                                       This paper                          N/A
  tetOFF-*EGFP*^PTC-35^ cells                                                                                        This paper                          N/A
  HCT116                                                                                                             ATCC                                CCL-247
  HEK293T                                                                                                            ATCC                                CRL-3216
  HeLa                                                                                                               ATCC                                CCL-2
  Oligonucleotides                                                                                                                                       
  Sequences of oligonucleotides used in this study provided in [Table S3](#SD4){ref-type="supplementary-material"}   This paper                          N/A
  Recombinant DNA                                                                                                                                        
  pAAVS-*EGFP*^PTC-231^                                                                                              This paper                          N/A
  pAAVS-*EGFP*^PTC-35^                                                                                               This paper                          N/A
  tetOFF-*EGFP*^PTC-231^                                                                                             This paper                          N/A
  tetOFF-*EGFP*^PTC-35^                                                                                              This paper                          N/A
  XLone-MCS                                                                                                          This paper                          N/A
  XLone-tTA-MCS                                                                                                      This paper                          N/A
  XLone-GFP                                                                                                          Addgene (Xiaojun Lian)              Cat\# 96930 ([@R73])
  pCMV-hyPBase                                                                                                       Nancy Craig                         [@R99]
  Human CRISPR Knockout Pooled Library (Brunello)                                                                    Addgene (David Root, John Doench)   Cat\# 73179 ([@R18])
  lentiCRISPR v2                                                                                                     Addgene (Feng Zhang)                Cat\# 52961 ([@R79])
  psPAX2                                                                                                             Addgene (Didier Trono)              Cat\# 12260
  pMD2.G                                                                                                             Addgene (Didier Trono)              Cat\# 12259
  hAAVS1 1L TALEN                                                                                                    Addgene (Feng Zhang)                Cat\# 35431 ([@R78])
  hAAVS1 1R TALEN                                                                                                    Addgene (Feng Zhang)                Cat\# 35432 ([@R78])
  pAAVS-*EGFP*-DONOR                                                                                                 Joshua Mendell                      [@R56]
  pGL3-Renilla-Ter-Firefiy                                                                                           This paper                          N/A
  pGL3-Renilla-noTer-Firefly                                                                                         This paper                          N/A
  pGL3-Control                                                                                                       Promega Corporation                 Cat\# E1741
  Software and Algorithms                                                                                                                                
  Bowtie2                                                                                                            [@R47]                              N/A
  MAGeCK                                                                                                             [@R51]                              N/A
  STAR                                                                                                               [@R17]                              N/A
  featureCounts                                                                                                      [@R53]                              N/A
  edgeR                                                                                                              [@R74]                              N/A

###### Highlights

-   A genome-wide CRISPR screen identifies regulators and components of the NMD pathway

-   ABCE1 is required for NMD and other forms of 3′ UTR-mediated regulation

-   Upon ABCE1 loss, ribosomes move into 3′ UTRs and displace bound regulators

-   Iron deficiency and oxidative stress impair ABCE1 and post-transcriptional control
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